Multiple Sclerosis pills have been dreamed of as the “holy grail”.  New MS pills are in the works, some in very late stages of the approval process that offers hope for the millions of MS sufferers worldwide.  Most current treatment involves either injections or intravenous therapy that involves steroids, interferon, and similar toxic drugs.  The Ms pills currently under study offer a lot more convenience but don’t offer significant improvement or relief from sometimes horrible side effects.  The two most promising Multiple Sclerosis pills under study as of 2010 are cladribine, made by Merck and marketed under the name Serono, and Fingolimod, made by Novartis.  Sereno is already approved by the FDA but not as one of the new MS pills.  Instead, it is approved for treatment of some of the blood cancers.  Both of the Multiple Sclerosis pills are shown to be effective, and both are being developed to …